- Home
- GNK vs ALVO Comparison
GNK vs ALVO Comparison
Compare GNK & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GNK | ALVO |
|---|---|---|
| Founded | 2004 | 2013 |
| Country | United States | Luxembourg |
| Employees | 1056 | 1460 |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | GNK | ALVO |
|---|---|---|
| Price | $26.57 | $3.06 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $19.00 | $8.00 |
| AVG Volume (30 Days) | 264.3K | ★ 638.7K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.90% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.21 | N/A |
| Revenue | ★ $342,054,000.00 | N/A |
| Revenue This Year | $21.15 | $13.28 |
| Revenue Next Year | $1.41 | $18.63 |
| P/E Ratio | $122.62 | ★ $18.20 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $15.51 | $2.94 |
| 52 Week High | $27.25 | $9.94 |
Technical Indicators
Market Signals| Indicator | GNK | ALVO |
|---|---|---|
| Relative Strength Index (RSI) | 62.15 | 35.84 |
| Support Level | $22.78 | $2.99 |
| Resistance Level | $27.25 | $3.94 |
| Average True Range (ATR) | 0.75 | 0.17 |
| MACD | 0.09 | -0.03 |
| Stochastic Oscillator | 97.93 | 0.98 |
Price Performance
Historical ComparisonAbout GNK Genco Shipping & Trading Limited New (Marshall Islands)
Genco Shipping & Trading Ltd is an international shipping company specializing in the transportation of iron ore, coal, grain, steel products and other drybulk cargoes. It is involved in the ocean transportation of drybulk cargoes. The company operates in one segment, with two reportable segment: Major and Minor bulk fleet. It generates revenue through time charter agreements, spot market voyage charters, pool agreements and spot market-related time charters. oyage revenues also include the sale of bunkers consumed during short-term time charters pursuant to the terms of the time charter agreement.
About ALVO Alvotech
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.